Related Experiment Video
Updated: May 23, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Exploring the impact of ambient air PM2.5 on multiple sclerosis: an experimental dive into neuroinflammation
Shilan Mozaffari1, Mohammad Sadegh Hassanvand2,3, Maryam Baeeri1
1Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
There is mounting evidence about the connection between particulate matter (PM) and neuroinflammation. This study aimed to evaluate the toxicological effects of PM2.5 associated with inflammatory factors in a mouse's multiple sclerosis (MS) model. Thirty C57BL/6 male mice were categorized into five groups: a group of healthy mice, a control cuprizone-induced MS group, and three MS-induced groups, intranasally exposed to three concentrations of ambient air PM2.5 (5, 10, and 20 mg/mL) from Tehran in a phosphate-buffered saline (PBS) solution. All mice were investigated by motor function, molecular, and histopathological assays. Moreover, the chemical content of the collected PM2.5 was assessed and reported. The cumulative exposure doses were equal to 0.025, 0.05, and 0.1 mg per gram of body weight of mice, which were approximately 3.52, 7.04, and 14.08 times higher than the human daily dose in Tehran. The PM2.5-exposed groups showed a high inflammatory response characterized by a significant increase in the mRNA expression of tumor necrosis alpha (TNF-α), NLRP3, and interleukin 18 (IL-18). In addition, the PM2.5-exposed groups exhibited a notably lower velocity level, total traveled distance (TD), and duration traveled in the central zone (DC) than the control group. The histopathological assays revealed significant pathological alterations and demyelination in the PM2.5-exposed groups compared to the control group. Identifying the risks and reducing the likelihood of exposure through preventive measures and regulations can result in financial savings and improve the quality of life for MS patients.
Insights
Exposure to fine particulate matter (PM2.5) significantly worsens neuroinflammation and motor deficits in a mouse model of multiple sclerosis (MS). Reducing PM2.5 exposure may improve quality of life for MS patients.
Area of Science:
- Environmental Health
- Neuroscience
- Toxicology
Background:
- Growing evidence links particulate matter (PM) exposure to neuroinflammation.
- Multiple Sclerosis (MS) is a chronic neurological disease characterized by inflammation and demyelination.
Purpose of the Study:
- To investigate the toxicological impact of PM2.5 on a mouse model of MS.
- To assess the association between PM2.5 exposure and inflammatory factors in MS.
Main Methods:
- Thirty male C57BL/6 mice were divided into healthy, control MS, and three PM2.5-exposed MS groups.
- Mice were intranasally exposed to varying concentrations of ambient PM2.5 from Tehran.
- Evaluations included motor function tests, molecular assays (mRNA expression), and histopathological analysis.
Main Results:
- PM2.5 exposure significantly increased mRNA expression of TNF-α, NLRP3, and IL-18, indicating a heightened inflammatory response.
- Mice exposed to PM2.5 showed reduced motor function, including lower velocity, total traveled distance, and central zone activity.
- Histopathology revealed significant demyelination and pathological alterations in PM2.5-exposed groups.
Conclusions:
- PM2.5 exposure exacerbates neuroinflammation and neuropathology in an MS mouse model.
- Findings highlight the detrimental effects of air pollution on MS progression.
- Implementing preventive measures against PM2.5 exposure could improve patient outcomes and quality of life.
More Related Videos
08:48Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System
Published on: December 21, 2016
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022